Vontobel Holding’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-43,000
| Closed | -$23.2K | – | 1088 |
|
|
2024
Q4 | $23.2K | Hold |
43,000
| – | – | ﹤0.01% | 1089 |
|
|
2024
Q3 | $40.9K | Buy |
43,000
+30,000
| +231% | +$28.5K | ﹤0.01% | 1067 |
|
|
2024
Q2 | $12.6K | Sell |
13,000
-10,000
| -43% | -$9.72K | ﹤0.01% | 1066 |
|
|
2024
Q1 | $36.3K | Buy |
+23,000
| New | +$36.3K | ﹤0.01% | 1061 |
|
|
2021
Q4 | – | Sell |
-103,000
| Closed | -$533K | – | 1041 |
|
|
2021
Q3 | $533K | Buy |
103,000
+3,000
| +3% | +$15.5K | ﹤0.01% | 773 |
|
|
2021
Q2 | $426K | Hold |
100,000
| – | – | ﹤0.01% | 810 |
|
|
2021
Q1 | $531K | Buy |
100,000
+30,000
| +43% | +$159K | ﹤0.01% | 655 |
|
|
2020
Q4 | $377K | Buy |
+70,000
| New | +$377K | ﹤0.01% | 693 |
|